![]() |
NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, Feb. 23, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.
John Deere will preview CONEXPO on NYSE Live jwplayer(‘myplayer1’).setup(file: ‘https://mma.prnasia.com/media2/2918191/NYSE_Feb_23_Market_Update.mp4’, image: ‘https://mma.prnasia.com/media2/2918191/NYSE_Feb_23_Market_Update.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’);
Ashley Mastronardi delivers the pre-market update on February 23rd
- The New York Stock Exchange and equities markets will open today, as normal, despite the Northeast being hit by a historic winter blizzard.
- Leaders from CONEXPO-CON/AGG, billed as North America’s largest construction trade show, will join NYSE Live ahead of its next convention in Las Vegas in early March.
- The space industry is lifting off with fresh rounds of funding, with leaders from Gilmour Space and Aalyria joining NYSE Live to discuss how it will accelerate their growth.
- The ViVE 2026 digital health conference kicked off in Los Angeles on Sunday and NYSE is on the ground with content set to roll out across out platforms in the coming weeks.
Opening Bell
CONEXPO-CON/AGG celebrate the kickoff of North America’s largest construction trade show
Closing Bell
NYSE Floor Brokers ring the Closing Bell
For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com
Video – https://mma.prnasia.com/media2/2918191/NYSE_Feb_23_Market_Update.mp4
ข่าวที่เกี่ยวข้อง
- RoboSense Announces H1 2026 LiDAR Sales of 719,200 Units as Robotics Segment Grows by 510.4%
- STARCARES ร่วมมือกับ B-LEAD 2026 พร้อมส่งเสริม และพัฒนาธุรกิจชั้นนำของคนเวียดนามรุ่นใหม่
- Hushpitality Rising: Agoda Insights Point to a Growing Appetite for Slower Travel in India
- WuXi Biologics’ MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy

